Amneal Pharmaceuticals, Inc. AMRX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s change in other assets?
- Amneal Pharmaceuticals, Inc. (AMRX) reported change in other assets of $13.4M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s change in other assets changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s change in other assets increased by 2512.1% year-over-year, from $513K to $13.4M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.